Page last updated: 2024-12-08

paratose

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

paratose: RN given refers to (D-ribo)-isomer; see also record for colitose & tyvelose [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

D-paratose : A paratose that has D-configuration. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

paratose : A dideoxyhexose that is allose in which the hydroxy groups at positions 3 and 6 have been replaced by hydrogens. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID12303783
CHEBI ID63336
CHEBI ID63335
SCHEMBL ID22749079
MeSH IDM0079511

Synonyms (20)

Synonym
PAR ,
d-paratose
paratose
3,6-dideoxy-d-glucopyranose
KYPWIZMAJMNPMJ-IANNHFEVSA-N
paratosylalcohol
3,6-dideoxy-d-ribo-hexopyranose
3,6-dideoxy-d-ribose
3,6-dideoxy-ribo-hexopyranose
3,6-dideoxy-ribopyranose
3,6-dideoxy-d-ribopyranose
3,6-dideoxy-d-ribopyranoside
3,6-dideoxy-ribose
d-par
3,6-dideoxy-ribopyranoside
C21055
SCHEMBL22749079
chebi:63336
dtxcid20127622
chebi:63335
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (25.00)18.7374
1990's4 (50.00)18.2507
2000's1 (12.50)29.6817
2010's1 (12.50)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (12.50%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (87.50%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]